A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy
PHASE2
This study aims to evaluate the efficacy and safety of adebrelimab consolid...
The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer
PHASE3
To compare the efficiency between surgery and radiotherapy after SHR-1316 (...
Assessment of Adebelizumab Combined With Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
PHASE2
Immunotherapy combined with chemotherapy has emerged as the standard of car...
Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study
PHASE2
Neoadjuvant immunochemotherapy can effectively increase the postoperative p...
Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial
PHASE2
This study takes investigator-assessed Progression-Free Survival (PFS) as t...
Status
Not Yet Recruiting
Location
Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences